C. Le Péchoux

1991–2025 年に発表

118
論文数
20,004
被引用数
71
h 指数
116
i10 指数

被引用数

C. Le Péchoux の年別被引用数1971 年: 被引用 2 件1994 年: 被引用 2 件1995 年: 被引用 2 件1996 年: 被引用 1 件1997 年: 被引用 1 件1998 年: 被引用 2 件1999 年: 被引用 2 件2000 年: 被引用 5 件2001 年: 被引用 10 件2002 年: 被引用 8 件2003 年: 被引用 22 件2004 年: 被引用 25 件2005 年: 被引用 19 件2006 年: 被引用 11 件2007 年: 被引用 28 件2008 年: 被引用 28 件2009 年: 被引用 29 件2010 年: 被引用 64 件2011 年: 被引用 61 件2012 年: 被引用 74 件2013 年: 被引用 104 件2014 年: 被引用 104 件2015 年: 被引用 128 件2016 年: 被引用 157 件2017 年: 被引用 165 件2018 年: 被引用 106 件2019 年: 被引用 528 件2020 年: 被引用 792 件2021 年: 被引用 673 件2022 年: 被引用 513 件2023 年: 被引用 302 件2024 年: 被引用 554 件2025 年: 被引用 232 件2026 年: 被引用 7 件1972〜1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,263 件、この内訳の 18.3%中国: 引用元論文 698 件、この内訳の 10.1%フランス: 引用元論文 535 件、この内訳の 7.7%イタリア: 引用元論文 472 件、この内訳の 6.8%イギリス: 引用元論文 460 件、この内訳の 6.7%ドイツ: 引用元論文 390 件、この内訳の 5.6%オランダ: 引用元論文 388 件、この内訳の 5.6%カナダ: 引用元論文 287 件、この内訳の 4.2%スペイン: 引用元論文 247 件、この内訳の 3.6%スイス: 引用元論文 202 件、この内訳の 2.9%ベルギー: 引用元論文 190 件、この内訳の 2.7%日本: 引用元論文 189 件、この内訳の 2.7%
0%18.3%その他 23.1%

分野

  • Medicine83.1%
  • Biochemistry, Genetics and Molecular Biology7.2%
  • Engineering2.8%
  • Physics and Astronomy2.7%
  • Materials Science1.2%
  • Immunology and Microbiology1%
  • その他2%

トピック

  • Lung Cancer Diagnosis and Treatment9.5%
  • Lung Cancer Treatments and Mutations8.5%
  • Lung Cancer Research Studies8.1%
  • Sarcoma Diagnosis and Treatment6.2%
  • Cancer Immunotherapy and Biomarkers4.9%
  • Brain Metastases and Treatment2.9%
  • その他59.9%

共著者

全論文

検索で開く
  1. NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lore Lapeire, Sorin Dema, Gabriel Kacsó, Lyn Austen, Laurence Moureau-Zabotto, Vincent Servois, Eva Wardelmann, Philippe Terrier, Alexander J. Lazar, Judith V.M.G. Bovée, C. Le Péchoux, Z. Papaï - The Lancet Oncology 2019 被引用: 503

  2. Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 被引用: 1,879

  3. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 被引用: 570

  4. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis

    著者: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 被引用: 478

  5. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 被引用: 482

  6. Surgery in reference centers improves survival of sarcoma patients: a nationwide study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emmanuelle Bompas, Christine Chevreau, Florence Duffaud, María Rios, Christophe Perrin, Nelly Firmin, François Bertucci, C. Le Péchoux, François Le Loarer, Olivier Collard, Marie Karanian, Mehdi Brahmi, Armelle Dufresne, Aurélien Dupré, Françoise Ducimetière, Antoine Giraud, David Pérol, Maud Toulmonde, Isabelle Ray‐Coquard, Antoîne Italiano, Axel Le Cesne, Nicolas Penel, Sylvie Bonvalot - Annals of Oncology 2019 被引用: 332

  7. Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission

    著者: , , , , , , , , , , - New England Journal of Medicine 1999 被引用: 1,706

  8. Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anita Hiltbrunner, Mariana Pardo-Contreras, A. Gasca-Ruchti, Nino Giacomelli, Roswitha Kammler, Nesa Marti, Rita Pfister, Anne‐Christine Piguet, Susanne Roux, Sandra Troesch, M. Schneider, Robin Schweri, Isabel Zigomo, Zoi Tsourti, Panagiota Zygoura, S. Tsouprou, Marie Kassapian, Katerina Vervita, Georgia Dimopoulou, Charitini Andriakopoulou, Franck Morin, Elodie Amour, G. Mariaule, N. Archirel, María Dolores Arnaiz Fernández, E. Pereira, M. Fernandez, K. Lopez, Ainhoa Hernández, Sarah Chinchen, H. Jurkovic, Alan S. Livingstone, Jerry W. Mitchell, Macie B. Walker, Paul Mitchell, S. Ng, Christopher Steer, Karen Briscoe, Amina Saqib, Ehtesham Abdi, Baerin Houghton, Kenneth J. O’Byrne, B.R. Chittajallu, Brett Hughes, A. Black, Kristiaan Nackaerts, Henrica M.J. Werner, R. Gervais, Gérard Zalcman, F. Vaylet, P. Merle, I. Monnet, Denis Moro‐Sibilot, Olivier Molinier, Nicolas Girard, P.-J. Souquet, Fabrice Barlési, D. Debieuvre, Hélène Senellart, M. Poudenx, A. Dixmier, Damien Pouessel, Jacques Cadranel, H. Léna, Élisabeth Quoix, S. Friard, Clarisse Audigier-Valette, Julien Mazières, Éric Pichon, Martin Faehling ほか 20 名 - Annals of Oncology 2021 被引用: 114

  9. Outcome of Patients with Non–Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2019 被引用: 242

  10. A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 被引用: 59

  11. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rafael Rosell, Giorgio V. Scagliotti, Lesley Seymour, Frances A. Shepherd, Richard Sylvester, Hirohito Tada, Fumihiro Tanaka, Valter Torri, David Waller, Ying Liang, for the Non-Small Cell Lung Cancer Collaborative Group - Cochrane Database of Systematic Reviews 2015 被引用: 366

  12. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data

    著者: , , , , , , , , , , , , , , - The Lancet 2010 被引用: 630

  13. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Egbert F. Smit, Peter Meldgaard, Alex A. Adjei, M. Nicolson, Lucio Crinò, Paul Van Schil, Suresh Senan, Corinne Faivre‐Finn, Gaetano Rocco, Paolo Veronesi, Jean-Yves Douillard, Eric Lim, Christophe Dooms, W. Weder, Dirk De Ruysscher, C. Le Péchoux, Paul De Leyn, Virginie Westeel - Annals of Oncology 2014 被引用: 495

  14. First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas

    著者: , , , , , , , , , , , , , , , - Clinical Cancer Research 2016 被引用: 234

  15. Radiotherapy for Management of Extremity Soft Tissue Sarcomas: Why, When, and Where?

    著者: , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2012 被引用: 260

  16. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Nicolson, Lucio Crinò, Paul Van Schil, Suresh Senan, Corinne Faivre‐Finn, Gaetano Rocco, Giulia Veronesi, Jean-Yves Douillard, Eric Lim, Christophe Dooms, Walter Weder, Dirk De Ruysscher, C. Le Péchoux, Paul De Leyn, Virginie Westeel - Annals of Oncology 2015 被引用: 398

  17. Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mikaela Dimitriu, Patricia Said, Alexander J. Lazar, Judith V.M.G. Bovée, C. Le Péchoux, Z. Papaï - International Journal of Radiation Oncology*Biology*Physics 2022 被引用: 44

  18. Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 396

  19. Aggressive Surgery in Retroperitoneal Soft Tissue Sarcoma Carried Out at High-Volume Centers is Safe and is Associated With Improved Local Control

    著者: , , , , , , , , , , , - Annals of Surgical Oncology 2010 被引用: 330

  20. Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2013 被引用: 245

  21. European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer

    著者: , , , , , , , , - Radiotherapy and Oncology 2017 被引用: 214

  22. Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France

    著者: , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2016 被引用: 163

  23. Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors

    著者: , , , , , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2019 被引用: 133

  24. Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2019 被引用: 76